Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,134 | 389 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,233 | 98 | $0 (2024) |
| Novo Nordisk Inc | $785.41 | 40 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $435.36 | 29 | $0 (2024) |
| Lilly USA, LLC | $427.91 | 35 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $363.60 | 22 | $0 (2024) |
| PFIZER INC. | $309.59 | 22 | $0 (2024) |
| Merck Sharp & Dohme LLC | $307.04 | 19 | $0 (2023) |
| Mylan Specialty L.P. | $270.03 | 14 | $0 (2024) |
| Lundbeck LLC | $256.64 | 13 | $0 (2024) |
| Amgen Inc. | $217.10 | 17 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,511 | 94 | Lundbeck LLC ($240.31) |
| 2023 | $1,922 | 124 | ABBVIE INC. ($564.31) |
| 2022 | $1,463 | 88 | ABBVIE INC. ($299.85) |
| 2021 | $1,238 | 83 | Novo Nordisk Inc ($219.37) |
All Payment Transactions
389 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $24.87 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.32 | General |
| Category: NEUROLOGY | ||||||
| 11/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Obesity | ||||||
| 10/31/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.73 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Neuropsychiatry | ||||||
| 10/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: PAIN | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.68 | General |
| Category: NEUROLOGY | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Respiratory | ||||||
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.30 | General |
| Category: PSYCHIATRY | ||||||
| 08/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: PAIN | ||||||
| 08/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Cardio-renal | ||||||
| 08/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Obesity | ||||||
| 08/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: UROLOGY | ||||||
| 08/06/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.68 | General |
| Category: NEUROLOGY | ||||||
| 08/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: Diabetes | ||||||
| 08/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $2.07 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 47 | 51 | $3,597 | $818.23 |
| 2022 | 2 | 55 | 71 | $2,952 | $1,992 |
| 2021 | 3 | 72 | 75 | $6,720 | $2,944 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 11 | 12 | $1,032 | $257.80 | 25.0% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 11 | 11 | $825.00 | $208.00 | 25.2% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 13 | 13 | $810.00 | $203.75 | 25.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 12 | 15 | $930.00 | $148.68 | 16.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 42 | 45 | $2,250 | $1,568 | 69.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 13 | 26 | $702.00 | $424.00 | 60.4% |
| 87428 | Sarscov & inf vir a&b ag ia | Office | 2021 | 24 | 25 | $4,154 | $1,590 | 38.3% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 28 | 28 | $1,400 | $989.24 | 70.7% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 20 | 22 | $1,166 | $364.54 | 31.3% |
About Jeffrey Whitby, APRN
Jeffrey Whitby, APRN is a Nurse Practitioner healthcare provider based in Trenton, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2021. The National Provider Identifier (NPI) number assigned to this provider is 1316537053.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jeffrey Whitby, APRN has received a total of $6,134 in payments from pharmaceutical and medical device companies, with $1,511 received in 2024. These payments were reported across 389 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($6,134).
As a Medicare-enrolled provider, Whitby has provided services to 174 Medicare beneficiaries, totaling 197 services with total Medicare billing of $5,753. Data is available for 3 years (2021–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Trenton, TN
- Active Since 01/26/2021
- Last Updated 01/26/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1316537053
Products in Payments
- VRAYLAR (Drug) $748.21
- NURTEC ODT (Drug) $409.70
- REXULTI (Drug) $381.18
- FARXIGA (Drug) $287.15
- Wegovy (Drug) $282.53
- QULIPTA (Drug) $212.86
- BELSOMRA (Drug) $201.09
- Ozempic (Drug) $199.30
- Kerendia (Drug) $179.39
- Rybelsus (Drug) $177.20
- UBRELVY (Drug) $166.43
- Otezla (Drug) $166.36
- TRELEGY ELLIPTA (Drug) $166.21
- Yupelri (Drug) $151.34
- TRULICITY (Drug) $147.01
- GEMTESA (Drug) $141.60
- JARDIANCE (Drug) $119.08
- YUPELRI (Drug) $118.69
- VYEPTI (Biological) $112.28
- BREZTRI (Drug) $107.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Trenton
Renee Mclean, Np, NP
Nurse Practitioner — Payments: $8,334
Mrs. Sherry Whitby, Fnp, FNP
Nurse Practitioner — Payments: $8,065
Jan Altiser, Pmhnp-Bc, PMHNP-BC
Nurse Practitioner — Payments: $2,922
Mary Bucci, Np, NP
Nurse Practitioner — Payments: $1,747
Lynda Collins, Apn, APN
Nurse Practitioner — Payments: $1,070
Nancy Rowell-Crane, Np-C, NP-C
Nurse Practitioner — Payments: $342.84